Mdc Partners (MDCA) Shareholder Frontfour Capital Group Has Lowered Its Holding by $2.26 Million as Market Value Declined; Capital Management Associates Has Increased Cvs Health (CVS) Stake by $1.08 Million

April 18, 2018 - By Winifred Garcia

MDC Partners Inc. (NASDAQ:MDCA) Logo

Capital Management Associates increased its stake in Cvs Health Corporation (CVS) by 287.88% based on its latest 2017Q4 regulatory filing with the SEC. Capital Management Associates bought 14,970 shares as the company’s stock declined 17.45% with the market. The institutional investor held 20,170 shares of the medical and nursing services company at the end of 2017Q4, valued at $1.46 million, up from 5,200 at the end of the previous reported quarter. Capital Management Associates who had been investing in Cvs Health Corporation for a number of months, seems to be bullish on the $67.83B market cap company. The stock decreased 0.57% or $0.38 during the last trading session, reaching $66.73. About 5.01 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 18, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Frontfour Capital Group Llc decreased its stake in Mdc Partners Inc (MDCA) by 30.76% based on its latest 2017Q4 regulatory filing with the SEC. Frontfour Capital Group Llc sold 250,826 shares as the company’s stock declined 31.53% with the market. The hedge fund held 564,714 shares of the advertising company at the end of 2017Q4, valued at $5.51 million, down from 815,540 at the end of the previous reported quarter. Frontfour Capital Group Llc who had been investing in Mdc Partners Inc for a number of months, seems to be less bullish one the $487.47 million market cap company. It closed at $8.2 lastly. It is up 24.86% since April 18, 2017 and is downtrending. It has underperformed by 36.41% the S&P500.

Since February 16, 2018, it had 0 insider purchases, and 1 sale for $1.42 million activity.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It dived, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Fernwood Invest Management Limited Liability Company holds 1.82% or 46,873 shares. Newfocus Financial Gru Limited Company owns 9,725 shares or 0.43% of their US portfolio. Tdam Usa Incorporated holds 0.11% of its portfolio in CVS Health Corporation (NYSE:CVS) for 27,563 shares. Timber Hill Ltd Liability Company reported 9,736 shares. Northern Capital Management Ltd reported 46,650 shares. Oakworth invested 0.04% in CVS Health Corporation (NYSE:CVS). Boston Private Wealth Ltd owns 189,286 shares for 0.52% of their portfolio. Markel Corporation has invested 0.37% in CVS Health Corporation (NYSE:CVS). Nwq Inv Mngmt has 73,212 shares for 0.07% of their portfolio. Piedmont Advisors Limited Liability Co has 285,176 shares. M&R Capital Management invested 1.03% in CVS Health Corporation (NYSE:CVS). First Comml Bank holds 0.08% or 6,645 shares in its portfolio. Butensky & Cohen Fincl Security Inc holds 25,042 shares. Hancock Hldg reported 21,059 shares stake. Lombard Odier Asset Management (Switzerland) reported 57,887 shares.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 75 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was initiated by UBS on Thursday, October 6 with “Buy”. Needham upgraded CVS Health Corporation (NYSE:CVS) on Friday, November 10 to “Buy” rating. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Monday, December 4 by RBC Capital Markets. The rating was maintained by Jefferies with “Hold” on Tuesday, November 7. The firm earned “Buy” rating on Tuesday, November 21 by Leerink Swann. As per Monday, August 14, the company rating was downgraded by Wolfe Research. The rating was maintained by Citigroup with “Neutral” on Friday, November 3. Tigress Financial maintained CVS Health Corporation (NYSE:CVS) on Tuesday, December 26 with “Buy” rating. The stock has “Hold” rating by Deutsche Bank on Thursday, August 20. As per Wednesday, January 17, the company rating was maintained by Robert W. Baird.

Analysts await MDC Partners Inc. (NASDAQ:MDCA) to report earnings on April, 26. They expect $-0.06 earnings per share, up 71.43% or $0.15 from last year’s $-0.21 per share. After $0.22 actual earnings per share reported by MDC Partners Inc. for the previous quarter, Wall Street now forecasts -127.27% negative EPS growth.

Investors sentiment increased to 1.49 in Q4 2017. Its up 0.20, from 1.29 in 2017Q3. It increased, as 15 investors sold MDCA shares while 32 reduced holdings. 30 funds opened positions while 40 raised stakes. 45.41 million shares or 0.08% more from 45.38 million shares in 2017Q3 were reported. Fuller And Thaler Asset Management Incorporated reported 0.03% in MDC Partners Inc. (NASDAQ:MDCA). Morgan Stanley accumulated 123,928 shares. Credit Suisse Ag owns 0% invested in MDC Partners Inc. (NASDAQ:MDCA) for 65,774 shares. Vanguard Gp accumulated 1.69M shares or 0% of the stock. Prudential accumulated 30,431 shares or 0% of the stock. Voya Investment Mngmt Limited Liability stated it has 25,906 shares. 257 were accumulated by Fifth Third Comml Bank. Stonebridge Management Inc reported 17,225 shares. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 3,567 shares. State Board Of Administration Of Florida Retirement Systems owns 47,469 shares. 61,503 were reported by California Employees Retirement Systems. The Massachusetts-based Massachusetts Fincl Ser Ma has invested 0% in MDC Partners Inc. (NASDAQ:MDCA). Barclays Public Limited Com holds 0% or 59,543 shares. Moreover, Gmt Corporation has 0.08% invested in MDC Partners Inc. (NASDAQ:MDCA) for 378,153 shares. Sg Americas Ltd Limited Liability Company owns 21,070 shares.

MDC Partners Inc. (NASDAQ:MDCA) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>